dr. garon on the expanding treatment landscape in lung cancer
Published 4 years ago • 98 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:25
dr. garon on incorporating immunotherapies into lung cancer treatment
-
1:25
dr. garon on antiangiogenic agents in lung cancer
-
0:54
dr. garon on immunotherapy for patients with nsclc
-
0:47
dr. edward garon on the future of combination treatments in lung cancer
-
1:14
dr. garon discusses immunotherapy as salvage treatment for advanced lung cancer
-
1:27
dr. schenk on the evolving treatment landscape in lung cancer
-
1:59
dr. garon on sequencing of agents for advanced lung cancer
-
1:04
dr. garon on immunotherapy in stage iii unresectable nsclc
-
1:01
dr. garon on the keynote-001 study in nsclc
-
1:22
dr. garon on future of immunotherapy in nsclc
-
2:13
dr garon on considerations for perioperative immunotherapy use in lung cancer
-
2:30
dr. garon on concerns for immunotherapy combinations in lung cancer
-
0:56
dr. garon on potential for immunotherapy in egfr nsclc
-
1:10
dr. garon on the role of trastuzumab deruxtecan in lung cancer
-
1:07
dr. garon on differences between antiangiogenic agents in lung cancer
-
2:00
dr. edward garon—connecting for lung cancer cures
-
2:39
edward garon md, expounds on the new fda approval of erlotinib ramuciramab in egfr positive ansclc
-
3:16
a changing treatment landscape in advanced lung cancer
-
1:29
dr. garon discusses the checkmate-384 study in nsclc